PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool L69 7SX, UK. Electronic address: A.Amara@liverpool.ac.uk.\', \'Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool L69 7SX, UK.\', \'The Royal Liverpool & Broadgreen University Hospitals NHS Trust, Prescot Road, Liverpool L7 8XP, UK.\', \'Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK.\', \'Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool L69 7SX, UK; The Royal Liverpool & Broadgreen University Hospitals NHS Trust, Prescot Road, Liverpool L7 8XP, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0731-7085(21)00467-210.1016/j.jpba.2021.114356
?:hasPublicationType
?:journal
  • Journal of pharmaceutical and biomedical analysis
is ?:pmid of
?:pmid
?:pmid
  • 34509661
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.919
?:rankingScore_hIndex
  • 108
is ?:relation_isRelatedTo_publication of
?:title
  • The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34509661>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34509661>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all